Evidence map›Paper›PMID 32404022›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2021

CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Mustafa Balkaya, Il-Doo Kim, Faariah Shakil, Sunghee Cho

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Obesity-induced Ly6CJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  10. Article
  11. Role of CD36 in central nervous system diseases.Neural regeneration research · 2024
    Review
  12. Review
  13. Review
  14. CRTC1 is a potential target to delay aging-induced cognitive deficit by protecting the integrity of the blood-brain barrier via inhibiting inflammation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  15. Endothelial cell CD36 mediates stroke-induced brain injury via BBB dysfunction and monocyte infiltration in normal and obese conditions.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. In Vivo Evaluation of BBB Integrity in the Post-stroke Brain.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mustafa BalkayaBurke Neurological Research Institute, White Plains, NY, USA.
Il-Doo KimBurke Neurological Research Institute, White Plains, NY, USA.
Faariah ShakilBurke Neurological Research Institute, White Plains, NY, USA.
Sunghee ChoBurke Neurological Research Institute, White Plains, NY, USA.
Burke Rehabilitation Hospital · USNeurological Research Institute · US

Funding

The role of CD36 in ischemic inflammation and injuryR01HL082511 · NHLBI · WINIFRED MASTERSON BURKE MED RES INST · PI CHO, SUNGHEE · 2006 to 2014
$4.4M
Role of CD36 in functional recovery in chronic strokeR01NS095359 · NINDS · WINIFRED MASTERSON BURKE MED RES INST · PI CHO, SUNGHEE · 2015 to 2019
$2.1M
Targeting stroke-induced brain swelling in obese subjects: role of VEGFR01NS103326 · NINDS · WINIFRED MASTERSON BURKE MED RES INST · PI CHO, SUNGHEE · 2018 to 2022
$2.0M
Impact of BDNF SNP on stroke-induced plasticity and motor functionR01NS077897 · NINDS · WINIFRED MASTERSON BURKE MED RES INST · PI CHO, SUNGHEE · 2012 to 2016
$2.0M
NHLBI NIH HHS R01 HL082511NINDS NIH HHS R01 NS077897NINDS NIH HHS R01 NS095359NINDS NIH HHS R01 NS103326
6 · The paper itself

Abstract

Ameliorating blood-brain barrier disruption and altering scar formation dynamics are potential strategies that may improve post-stroke recovery. CD36 is a class B scavenger receptor that plays a role in innate immunity, inflammation and vascular dysfunction and regulates post-stroke injury, neovascularization, reactive astrogliosis and scar formation. By subjecting WT and CD36KO mice to different MCAo occlusion durations to generate comparable acute lesion sizes, we addressed the role of CD36 in BBB dysfunction, scar formation and recovery. The majority of stroke recovery studies primarily focus on motor function. Here, we employed an extensive behavioral test arsenal to evaluate psychological and cognitive endpoints. While not evident during the acute phase, CD36 deficient mice displayed significantly attenuated BBB leakage and scar formation at three months after stroke compared to wild-type littermates. Assessment of motor (open field, rotarod), anxiety (plus maze, light-dark box), depression (forced swim, sucrose preference) and memory tests (water maze) revealed that CD36 deficiency ameliorated stroke-induced behavioral impairments in activity, hedonic responses and spatial learning and strategy switching. Our findings indicate that CD36 contributes to stroke-induced BBB dysfunction and scar formation in an injury-independent manner, as well as to the chronic motor and neurophysiological deficits in chronic stroke.

Indexed as

AnimalsAnxietyBlood-Brain BarrierCD36 AntigensCicatrixDepressionDisease Models, AnimalInfarction, Middle Cerebral ArteryIschemic StrokeLocomotionMaze LearningMiceMice, Inbred C57BLMice, KnockoutCD36 Antigensanhedoniablood–brain barrierCD36depressionscar tissuestroke

Identifiers

PMID32404022
PMCPMC7922745
OpenAlexW3025493721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.